Effects of CYP2D6 Polymorphism in Cardiovascular Patients Receiving Metoprolol: A Systematic Review and Meta-Analysis
Cardiovascular Research Prove Journal · 01.06.2026 · 10 (1) · 0-0
DOI: 10.21608/cvrepj.2026.509753 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Cardiovascular Research Prove Journal, online erschienen am 01.06.2026. Verfasst von Eman Youssef und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Youssef, E., Almosilhy, N. A., Shaheen, H. M., Issa, E. A., & Aldiban, W. (2026). Effects of CYP2D6 Polymorphism in Cardiovascular Patients Receiving Metoprolol: A Systematic Review and Meta-Analysis. Cardiovascular Research Prove Journal, 10(1), 0-0. https://doi.org/10.21608/cvrepj.2026.509753
Vancouver
Youssef E, Almosilhy NA, Shaheen HM, Issa EA, Aldiban W. Effects of CYP2D6 Polymorphism in Cardiovascular Patients Receiving Metoprolol: A Systematic Review and Meta-Analysis. Cardiovascular Research Prove Journal. 2026;10(1):0-0. doi:10.21608/cvrepj.2026.509753
BibTeX
@article{Youssef2026,
author = {Youssef, Eman and Almosilhy, Nereen A . and Shaheen, Hassan M. and Issa, El-Sayed A. and Aldiban, Weam},
title = {Effects of CYP2D6 Polymorphism in Cardiovascular Patients Receiving Metoprolol: A Systematic Review and Meta-Analysis},
journal = {Cardiovascular Research Prove Journal},
year = {2026},
volume = {10},
number = {1},
pages = {0--0},
doi = {10.21608/cvrepj.2026.509753}
}
EUVIMED